Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2014

01.09.2014 | Original Article

Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients

verfasst von: Sven F. Garbade, Cheryl R. Greenberg, Mübeccel Demirkol, Gülden Gökçay, Antonia Ribes, Jaume Campistol, Alberto B. Burlina, Peter Burgard, Stefan Kölker

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Glutaric aciduria type I (GA-I) is a cerebral organic aciduria caused by inherited deficiency of glutaryl-CoA dehydrogenase and is characterized biochemically by an accumulation of putatively neurotoxic dicarboxylic metabolites. The majority of untreated patients develops a complex movement disorder with predominant dystonia during age 3–36 months. Magnetic resonance imaging (MRI) studies have demonstrated striatal and extrastriatal abnormalities.

Aims/methods

The major aim of this study was to elucidate the complex neuroradiological pattern of patients with GA-I and to associate the MRI findings with the severity of predominant neurological symptoms. In 180 patients, detailed information about the neurological presentation and brain region-specific MRI abnormalities were obtained via a standardized questionnaire.

Results

Patients with a movement disorder had more often MRI abnormalities in putamen, caudate, cortex, ventricles and external CSF spaces than patients without or with minor neurological symptoms. Putaminal MRI changes and strongly dilated ventricles were identified as the most reliable predictors of a movement disorder. In contrast, abnormalities in globus pallidus were not clearly associated with a movement disorder. Caudate and putamen as well as cortex, ventricles and external CSF spaces clearly collocalized on a two-dimensional map demonstrating statistical similarity and suggesting the same underlying pathomechanism.

Conclusions

This study demonstrates that complex statistical methods are useful to decipher the age-dependent and region-specific MRI patterns of rare neurometabolic diseases and that these methods are helpful to elucidate the clinical relevance of specific MRI findings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300
Zurück zum Zitat Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ, Wilcken B (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31:503–507PubMedCrossRef Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ, Wilcken B (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31:503–507PubMedCrossRef
Zurück zum Zitat Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94:287–291PubMedCrossRef Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94:287–291PubMedCrossRef
Zurück zum Zitat Busquets C, Merinero B, Christensen E et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315–322PubMedCrossRef Busquets C, Merinero B, Christensen E et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315–322PubMedCrossRef
Zurück zum Zitat Chow CW, Haan EA, Goodman SI et al (1988) Neuropathology in glutaric acidemia type 1. Acta Neuropathol 76:590–594PubMedCrossRef Chow CW, Haan EA, Goodman SI et al (1988) Neuropathology in glutaric acidemia type 1. Acta Neuropathol 76:590–594PubMedCrossRef
Zurück zum Zitat Couce ML, López-Suárez O, Bóveda MD et al (2013) Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol 74:383–389CrossRef Couce ML, López-Suárez O, Bóveda MD et al (2013) Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. Eur J Paediatr Neurol 74:383–389CrossRef
Zurück zum Zitat Funk CB, Prasad AN, Frosk P et al (2005) Neuropathological, biochemical, and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722PubMedCrossRef Funk CB, Prasad AN, Frosk P et al (2005) Neuropathological, biochemical, and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722PubMedCrossRef
Zurück zum Zitat Gerstner B, Gratopp A, Marcinkowski M, Sifringer M, Obladen M, Buhrer C (2005) Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatr Res 57:771–776PubMedCrossRef Gerstner B, Gratopp A, Marcinkowski M, Sifringer M, Obladen M, Buhrer C (2005) Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatr Res 57:771–776PubMedCrossRef
Zurück zum Zitat Gitiaux C, Roze E, Kinugawa K et al (2008) Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 23:2392–2397PubMedCrossRef Gitiaux C, Roze E, Kinugawa K et al (2008) Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord 23:2392–2397PubMedCrossRef
Zurück zum Zitat Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: a “new” disorder of amino acid metabolism. Biochem Med 12:12–21PubMedCrossRef Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: a “new” disorder of amino acid metabolism. Biochem Med 12:12–21PubMedCrossRef
Zurück zum Zitat Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782PubMedCrossRef Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782PubMedCrossRef
Zurück zum Zitat Heringer J, Boy SPN, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752PubMedCrossRef Heringer J, Boy SPN, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752PubMedCrossRef
Zurück zum Zitat Hothorn T, Hornik K, Zeileis A (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15:651–674CrossRef Hothorn T, Hornik K, Zeileis A (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15:651–674CrossRef
Zurück zum Zitat Janos AL, Grange DK, Steiner RD, White DA (2012) Processing speed and executive abilities in children with phenylketonuria. Neuropsychology 26:735–743PubMedCentralPubMedCrossRef Janos AL, Grange DK, Steiner RD, White DA (2012) Processing speed and executive abilities in children with phenylketonuria. Neuropsychology 26:735–743PubMedCentralPubMedCrossRef
Zurück zum Zitat Kölker S, Sauer SW, Surtees RA, Leonard JV (2006a) The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. J Inherit Metab Dis 29:701–704PubMedCrossRef Kölker S, Sauer SW, Surtees RA, Leonard JV (2006a) The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. J Inherit Metab Dis 29:701–704PubMedCrossRef
Zurück zum Zitat Kölker S, Garbade SF, Greenberg CR et al (2006b) Natural history, outcome and therapeutic efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847PubMedCrossRef Kölker S, Garbade SF, Greenberg CR et al (2006b) Natural history, outcome and therapeutic efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847PubMedCrossRef
Zurück zum Zitat Kölker S, Garbade SF, Boy N et al (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363PubMedCrossRef Kölker S, Garbade SF, Boy N et al (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363PubMedCrossRef
Zurück zum Zitat Kölker S, Christensen E, Leonard JV et al (2011) Diagnosis and management of glutaric aciduria type I—revised recommendations. J Inherit Metab Dis 34:677–694PubMedCentralPubMedCrossRef Kölker S, Christensen E, Leonard JV et al (2011) Diagnosis and management of glutaric aciduria type I—revised recommendations. J Inherit Metab Dis 34:677–694PubMedCentralPubMedCrossRef
Zurück zum Zitat Kracun I, Rösner H, Cosovic C, Stavljenic A (1984) Topographical atlas of the gangliosides of the adult human brain. J Neurochem 43:979–989PubMedCrossRef Kracun I, Rösner H, Cosovic C, Stavljenic A (1984) Topographical atlas of the gangliosides of the adult human brain. J Neurochem 43:979–989PubMedCrossRef
Zurück zum Zitat Külkens S, Harting I, Sauer S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142–2144PubMedCrossRef Külkens S, Harting I, Sauer S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142–2144PubMedCrossRef
Zurück zum Zitat Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Mühlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytes to neuronal cells. J Biol Chem 286:17777–17784PubMedCentralPubMedCrossRef Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Mühlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytes to neuronal cells. J Biol Chem 286:17777–17784PubMedCentralPubMedCrossRef
Zurück zum Zitat Lin SK, Hsu SG, Ho ES et al (2002) Novel mutations and prenatal sonographic findings of glutaric aciduria (type I) in two Taiwanese families. Prenat Diagn 22:725–729PubMedCrossRef Lin SK, Hsu SG, Ho ES et al (2002) Novel mutations and prenatal sonographic findings of glutaric aciduria (type I) in two Taiwanese families. Prenat Diagn 22:725–729PubMedCrossRef
Zurück zum Zitat Neumaier-Probst E, Harting I, Seitz A, Ding C, Kölker S (2004) Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 27:869–876PubMedCrossRef Neumaier-Probst E, Harting I, Seitz A, Ding C, Kölker S (2004) Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 27:869–876PubMedCrossRef
Zurück zum Zitat Paradis E, Claude J, Strimmer K (2004) APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289–290PubMedCrossRef Paradis E, Claude J, Strimmer K (2004) APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289–290PubMedCrossRef
Zurück zum Zitat Pfeil J, Listl S, Hoffmann GF, Kölker S, Lindner M, Burgard P (2013) Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis 8:167PubMedCentralPubMedCrossRef Pfeil J, Listl S, Hoffmann GF, Kölker S, Lindner M, Burgard P (2013) Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis. Orphanet J Rare Dis 8:167PubMedCentralPubMedCrossRef
Zurück zum Zitat R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, ISBN 3-900051-07-0, URL http://www.R-project.org R Development Core Team (2012) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, ISBN 3-900051-07-0, URL http://​www.​R-project.​org
Zurück zum Zitat Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency, a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836PubMedCrossRef Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency, a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836PubMedCrossRef
Zurück zum Zitat Sauer SW, Okun JG, Fricker G et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids in glutaryl-coenzyme A dehydrogenase deficiency, a biochemical risk factor for neurodegeneration. J Neurochem 97:899–910PubMedCrossRef Sauer SW, Okun JG, Fricker G et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids in glutaryl-coenzyme A dehydrogenase deficiency, a biochemical risk factor for neurodegeneration. J Neurochem 97:899–910PubMedCrossRef
Zurück zum Zitat Sauer SW, Opp S, Mahringer A et al (2010) Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood–brain barrier and the choroid plexus. Biochim Biophys Acta 1802:552–560PubMedCrossRef Sauer SW, Opp S, Mahringer A et al (2010) Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood–brain barrier and the choroid plexus. Biochim Biophys Acta 1802:552–560PubMedCrossRef
Zurück zum Zitat Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170PubMedCrossRef Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170PubMedCrossRef
Zurück zum Zitat Soffer D, Amir N, Elpeleg ON et al (1992) Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neurol Sci 107:199–204PubMedCrossRef Soffer D, Amir N, Elpeleg ON et al (1992) Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neurol Sci 107:199–204PubMedCrossRef
Zurück zum Zitat Strauss KA, Lazovic J, Wintermark M, Morton DH (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920PubMedCrossRef Strauss KA, Lazovic J, Wintermark M, Morton DH (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920PubMedCrossRef
Zurück zum Zitat Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76–92PubMedCrossRef Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76–92PubMedCrossRef
Zurück zum Zitat Twomey EL, Naughten ER, Donoghue VB, Ryan S (2003) Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33:823–830PubMedCrossRef Twomey EL, Naughten ER, Donoghue VB, Ryan S (2003) Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33:823–830PubMedCrossRef
Zurück zum Zitat Van der Knaap MS, Valk J (2005) Myelination and retarded myelination. In: Van der Knaap MS, Valk J (eds) Magnetic resonance of myelination and myelin disorders, 3rd edn. Springer-Verlag, Berlin, pp 37–65CrossRef Van der Knaap MS, Valk J (2005) Myelination and retarded myelination. In: Van der Knaap MS, Valk J (eds) Magnetic resonance of myelination and myelin disorders, 3rd edn. Springer-Verlag, Berlin, pp 37–65CrossRef
Zurück zum Zitat Viau K, Ernst SL, Vanzo RJ, Botto LD, Pasquali M, Longo N (2012) Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab 106:430–438PubMedCrossRef Viau K, Ernst SL, Vanzo RJ, Botto LD, Pasquali M, Longo N (2012) Glutaric acidemia type 1: outcomes before and after expanded newborn screening. Mol Genet Metab 106:430–438PubMedCrossRef
Zurück zum Zitat Venables WN, Ripley BD (2002) Modern applied statistics with S, 4th edn. Springer, New YorkCrossRef Venables WN, Ripley BD (2002) Modern applied statistics with S, 4th edn. Springer, New YorkCrossRef
Zurück zum Zitat Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270PubMedCentralPubMedCrossRef Zinnanti WJ, Lazovic J, Housman C et al (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270PubMedCentralPubMedCrossRef
Metadaten
Titel
Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients
verfasst von
Sven F. Garbade
Cheryl R. Greenberg
Mübeccel Demirkol
Gülden Gökçay
Antonia Ribes
Jaume Campistol
Alberto B. Burlina
Peter Burgard
Stefan Kölker
Publikationsdatum
01.09.2014
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2014
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9676-9

Weitere Artikel der Ausgabe 5/2014

Journal of Inherited Metabolic Disease 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.